We believe it’s possible to have a profound impact on bending the cost curve in healthcare by building a pipeline of innovative medicines and bringing them to market at dramatically lower prices.

Bio

Robert Forrester has more than two decades of experience serving as chief executive officer or chief financial officer for both private and public biopharma companies. Prior to joining EQRx, Robert was CEO of Verastem Oncology, Chief Operating Officer or Chief Financial Officer at Forma Therapeutics, CombinatoRx (now ZLCS), and Coley Pharmaceutical Group. Robert also served as Managing Director of the Proprietary Investment Group at MeesPierson. He holds a LL.B. from Bristol University.

View All